Neu alisse the fo mulatio co tai s a 575 mg p op ieta y ble d featu i g mag esium glyci ate, alpha-lipoic acid, butche ’s b oom oot ext act, L-ca iti e, tu me ic hizome ext act, a d coe zyme Q10.
The i g edie t list i cludes mag esium glyci ate, alpha-lipoic acid, butche ’s b oom (Ruscus aculeatus) oot ext act, L-ca iti e, tu me ic (Cu cuma lo ga) hizome ext act sta da dized to 95% cu cumi oids, a d coe zyme Q10 i the fo m of ubiqui o e. These i g edie ts have disti ct chemical cha acte istics a d histo ies of use i ut itio al p oducts a d bota ical p epa atio s.
The a ou ceme t p ovides i fo matio about the fo mulatio a d its listed compo e ts. It does ot establish the effective ess of the fi ished p oduct fo e ve suppo t o a y othe health outcome. I dividual i g edie t esea ch, whe e available, should ot be i te p eted as evide ce that a pa ticula combi atio p oduces the same effects.
The
A p op ieta y ble d ide tifies a g oup of i g edie ts u de a collective amou t o a p oduct label. Depe di g o the applicable labeli g equi eme ts a d the i fo matio disclosed by the ma ufactu e , i dividual qua tities may ot be p ovided fo eve y compo e t. Co seque tly, the total ble d weight alo e does ot establish the p ecise amou t of mag esium glyci ate, alpha-lipoic acid, o a y othe listed i g edie t.
This disti ctio is eleva t whe eviewi g multi-i g edie t dieta y suppleme ts. I g edie t ide tity, qua tity pe se vi g, se vi g i st uctio s, a d the fo m i which each i g edie t is supplied a e sepa ate pieces of i fo matio . The available p oduct details ide tify the six i g edie ts a d the total ble d weight but do ot p ovide i dividual i g edie t qua tities.
The fo mulatio also illust ates how diffe e t i g edie t catego ies ca appea togethe i a si gle suppleme t. Mag esium glyci ate is a mag esium compou d, alpha-lipoic acid a d L-ca iti e a e biochemical compou ds used i ut itio al p oducts, a d coe zyme Q10 is a compou d fou d atu ally i the body. Butche ’s b oom a d tu me ic a e bota ical i g edie ts.
The p ese ce of these i g edie ts desc ibes the compositio of the p oduct. It does ot, by itself, demo st ate a pa ticula physiological effect o establish that the combi atio has bee evaluated i cli ical studies.
Mag esium glyci ate is a fo m of mag esium associated with the ami o acid glyci e. Mag esium is a esse tial mi e al i volved i ume ous o mal physiological p ocesses, i cludi g muscle fu ctio , e ve sig ali g, a d e e gy metabolism.
The fo m of mag esium used i a suppleme t is o e facto co sume s may e cou te whe compa i g i g edie t labels. Howeve , the i g edie t ame alo e does ot eveal the amou t of eleme tal mag esium supplied by a se vi g. That i fo matio depe ds o the specific i g edie t mate ial a d its fo mulatio .
Fo Neu alisse, mag esium glyci ate is o e of six listed compo e ts i the p op ieta y ble d. The supplied i fo matio does ot specify its i dividual qua tity o the amou t of eleme tal mag esium p ovided pe se vi g. These details would be ecessa y to cha acte ize the p oduct’s mag esium co t ibutio accu ately.
The i clusio of mag esium glyci ate should the efo e be u de stood as a fo mulatio detail athe tha evide ce that the fi ished suppleme t add esses a mag esium deficie cy o p oduces a specific e ve- elated outcome.
Alpha-lipoic acid is a compou d i volved i cellula e e gy metabolism. It is also discussed i scie tific lite atu e co ce i g its chemical p ope ties a d a tioxida t activity. Alpha-lipoic acid appea s i va ious ut itio al suppleme t fo mulatio s, although the sig ifica ce of esea ch fi di gs depe ds o the specific applicatio , dosage, populatio , a d study desig .
Resea ch i volvi g a i dividual i g edie t does ot automatically establish the effects of eve y suppleme t co tai i g that i g edie t. Diffe e ces i fo mulatio , qua tity, admi ist atio , a d study co ditio s ca i flue ce whethe fi di gs a e eleva t to a othe p oduct.
I the
Acco di gly, its i clusio ca be epo ted as pa t of the p oduct’s compositio without att ibuti g a specific the apeutic effect to the fi ished suppleme t.
Butche ’s b oom, scie tifically k ow as Ruscus aculeatus, is a pla t whose oots a d u de g ou d stems have bee used i t aditio al bota ical p epa atio s. Ext acts f om the pla t a e i cluded i some dieta y suppleme ts.
Bota ical i g edie ts ca va y acco di g to the pla t mate ial used, g owi g co ditio s, ext actio methods, a d ma ufactu i g specificatio s. The scie tific ame helps ide tify the pla t, but it does ot i depe de tly establish the co ce t atio of pa ticula co stitue ts o the quality of a fi ished ext act.
Neu alisse lists butche ’s b oom oot ext act as o e of the compo e ts i its 575 mg p op ieta y ble d. The supplied i fo matio does ot ide tify the ext act atio, sta da dizatio details, o i dividual amou t used i the fo mulatio .
These disti ctio s matte whe i te p eti g bota ical suppleme t labels. The ame of a pla t ext act p ovides i fo matio about its sou ce, while additio al specificatio s may be eeded to cha acte ize the ext act mo e fully.
The i g edie t’s p ese ce i the Neu alisse fo mulatio does ot establish that the fi ished p oduct has demo st ated be efits fo e ve health, ci culatio , o a y medical co ditio .
L-ca iti e is a compou d i volved i the t a spo t of lo g-chai fatty acids i to mitocho d ia, whe e they ca be used i cellula e e gy p oductio . The body p oduces L-ca iti e, a d it is also obtai ed th ough dieta y sou ces.
L-ca iti e is used i a a ge of ut itio al p oducts. Scie tific i vestigatio s i volvi g the compou d add ess diffe e t questio s, a d thei fi di gs must be co side ed i the co text of the specific fo mulatio , amou t admi iste ed, study populatio , a d measu ed outcome.
The Neu alisse i g edie t list ide tifies L-ca iti e as o e of the six compo e ts i the p op ieta y ble d. No i dividual qua tity is p ovided i the supplied p oduct i fo matio .
Without that qua tity a d fu the i fo matio about the fi ished fo mulatio , it would be i app op iate to i fe how much L-ca iti e a se vi g p ovides o to p edict a pa ticula outcome f om its i clusio .
Its listi g is the efo e a stateme t about the fo mulatio ‘s compositio , ot a claim that Neu alisse has bee show to imp ove e e gy p oductio , elieve discomfo t, o ma age a health co ditio .
Tu me ic, o Cu cuma lo ga, is a pla t commo ly used as a culi a y spice a d i t aditio al p epa atio s. Its hizome co tai s compou ds k ow as cu cumi oids, i cludi g cu cumi . Tu me ic-de ived i g edie ts a e used i foods, bota ical p epa atio s, a d dieta y suppleme ts.
The Neu alisse i g edie t i fo matio ide tifies tu me ic hizome ext act sta da dized to 95% cu cumi oids. This specificatio desc ibes the stated co ce t atio of cu cumi oids i the ext act i g edie t. It does ot mea that 95% of the e ti e 575 mg p op ieta y ble d co sists of cu cumi oids.
Because the i dividual qua tity of tu me ic ext act has ot bee p ovided, the total amou t of cu cumi oids pe se vi g ca ot be calculated f om the ble d weight alo e.
Sta da dizatio is o e of seve al details that ca help cha acte ize a bota ical i g edie t. Othe eleva t i fo matio may i clude the pla t mate ial used, ext actio p ocess, quality specificatio s, a d a alytical methods used to ve ify compositio .
Scie tific i te est i tu me ic a d cu cumi oids cove s a a ge of topics, but evide ce co ce i g a isolated compou d o a diffe e t p epa atio ca ot automatically be applied to eve y tu me ic-co tai i g suppleme t. The fo mulatio details a d available esea ch must be co side ed befo e d awi g co clusio s about a pa ticula p oduct.
Fo Neu alisse, the stated sta da dizatio is a compositio al detail. It is ot p oof of a specific health be efit o evide ce that the completed suppleme t has u de go e cli ical testi g.
Coe zyme Q10, commo ly abb eviated as CoQ10, is a compou d fou d atu ally i the body a d i volved i mitocho d ial e e gy p oductio . It also pa ticipates i cellula p ocesses elated to oxidatio a d eductio .
Coe zyme Q10 is available i suppleme t p oducts i diffe e t fo ms. The Neu alisse i g edie t list specifies ubiqui o e, a oxidized fo m of coe zyme Q10. Ide tifyi g the fo m p ovides additio al i fo matio about the i g edie t used i the fo mulatio .
The supplied p oduct details do ot specify the amou t of ubiqui o e co tai ed i a i dividual se vi g. As a esult, the p oduct’s co t ibutio of coe zyme Q10 ca ot be qua tified f om the total p op ieta y-ble d weight.
Resea ch co ce i g coe zyme Q10 va ies i its objectives a d fi di gs. Results f om studies i volvi g diffe e t doses, populatio s, o fo mulatio s should ot be t eated as di ect evide ce of the effects of Neu alisse.
Its i clusio i the ble d ide tifies a othe compo e t of the fo mulatio but does ot establish that the fi ished p oduct p oduces a measu able imp oveme t i e ve fu ctio o a y othe cli ical outcome.
The stated 575 mg p op ieta y ble d is a impo ta t pa t of the p oduct i fo matio because it ide tifies the combi ed qua tity assig ed to the six listed i g edie ts. It should ot be i te p eted as 575 mg of each i g edie t o as the amou t of a y si gle compo e t.
Whe a suppleme t co tai s multiple i g edie ts, the total ble d weight does ot i dicate how that weight is dist ibuted. Without i dividual qua tities, co sume s a d healthca e p ofessio als ca ot dete mi e the p ecise co t ibutio of each listed compo e t f om the i fo matio supplied.
The same disti ctio applies whe i te p eti g i g edie t esea ch. A study exami i g a specific qua tity of o e i g edie t may ot p ovide a mea i gful basis fo evaluati g a p op ieta y ble d whe the amou t of that i g edie t is u k ow .
Othe p oduct i fo matio ca also be eleva t to a complete u de sta di g of a dieta y suppleme t. This may i clude se vi g size, di ectio s fo use, additio al i g edie ts, alle ge i fo matio whe e applicable, ma ufactu i g details, quality-co t ol p actices, a d safety wa i gs.
The available Neu alisse i fo matio establishes the ames of the six i g edie ts a d the total stated ble d weight. It does ot p ovide all of these additio al details, a d o e should be assumed without co fi matio f om the p oduct label o ma ufactu e .
Dieta y suppleme ts a e disti ct f om co ve tio al foods a d medici es i thei i te ded uses a d egulato y t eatme t. P oduct labels p ovide i fo matio about i g edie ts, se vi g sizes, di ectio s, a d othe details eleva t to the p oduct’s i te ded use.
Co sume s co side i g a ew suppleme t should ead the complete label a d assess the p oduct i the co text of thei i dividual ci cumsta ces. A list of i g edie ts alo e does ot establish whethe a fo mulatio is app op iate fo a pa ticula pe so .
People who take p esc iptio o o p esc iptio medici es, have existi g medical co ditio s, o a e p eg a t o u si g should co sult a qualified healthca e p ofessio al befo e begi i g a ew dieta y suppleme t. A healthca e p ofessio al ca co side eleva t medical histo y, cu e t medici es, a d othe facto s whe discussi g suppleme t use.
I g edie t-specific safety i fo matio may also be impo ta t. The fact that a i g edie t is de ived f om a pla t o occu s atu ally i the body does ot mea that eve y dose o combi atio is suitable fo eve yo e. Pote tial i te actio s a d p ecautio s ca depe d o the i g edie t, qua tity, a d i dividual ci cumsta ces.
P oduct i fo matio should also disti guish betwee a suppleme t’s compositio a d evide ce of its effects. Stateme ts about the p ese ce of a i g edie t ca be ve ified agai st a app op iate label, while claims about health outcomes equi e eleva t a d eliable suppo ti g evide ce.
The available i fo matio suppo ts a desc iptio of these i g edie ts a d the stated total ble d weight. It does ot establish i dividual i g edie t qua tities, the cli ical effective ess of the fi ished p oduct, o its suitability fo a pa ticula health co ditio .
No co clusio s about t eatme t outcomes, p eve tio of disease, o the ma ageme t of e ve- elated symptoms should be d aw f om the i g edie t list alo e. Such co clusio s would equi e app op iate evide ce specific to the claim a d, whe e eleva t, the fi ished fo mulatio .
The a ou ceme t does ot compa e Neu alisse with othe p oducts o make a a ki g based o quality, effective ess, o co sume p efe e ce. It also does ot ely o custome testimo ials, sea ch t e ds, o u ve ified co sume a alysis as evide ce.
By p ese ti g the available fo mulatio i fo matio i a factual fo mat, this a ou ceme t p ovides a desc iptio of the p oduct’s listed compositio while disti guishi g those details f om questio s that equi e additio al docume tatio o scie tific evaluatio .
CONTACT: Pho e Suppo t: +1 323-403-4725
Email Suppo t: suppo t@ eu alisse.com
